tradingkey.logo

Harvard Bioscience Inc

HBIO

0.429USD

-0.007-1.63%
Market hours ETQuotes delayed by 15 min
18.97MMarket Cap
LossP/E TTM

Harvard Bioscience Inc

0.429

-0.007-1.63%
More Details of Harvard Bioscience Inc Company
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Company Info
Ticker SymbolHBIO
Company nameHarvard Bioscience Inc
IPO dateOct 21, 2013
CEOMr. John D. Duke
Number of employees330
Security typeOrdinary Share
Fiscal year-endOct 21
Address84 October Hill Rd
CityHOLLISTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code01746-1371
Phone15088938999
Websitehttps://www.harvardbioscience.com/
Ticker SymbolHBIO
IPO dateOct 21, 2013
CEOMr. John D. Duke
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Robert Benson
Robert Benson
Independent Director
Independent Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Robert Benson
Robert Benson
Independent Director
Independent Director
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
By RegionUSD
Name
Revenue
Proportion
United States
9.83M
45.13%
Europe, Middle East and Africa
6.03M
27.69%
China
2.73M
12.56%
Rest of Asia
2.35M
10.81%
Americas - Other
829.00K
3.81%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Instruments, equipment, software and accessories
19.86M
91.23%
Service, maintenance and warranty contracts
1.91M
8.77%
Shareholding Stats
Updated: Tue, May 27
Updated: Tue, May 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
AMH Equity, Ltd.
8.14%
Weber Capital Management, LLC
7.24%
BlackRock Institutional Trust Company, N.A.
5.75%
Harvey Partners, LLC
4.95%
The Vanguard Group, Inc.
4.84%
Other
69.08%
Shareholders
Shareholders
Proportion
AMH Equity, Ltd.
8.14%
Weber Capital Management, LLC
7.24%
BlackRock Institutional Trust Company, N.A.
5.75%
Harvey Partners, LLC
4.95%
The Vanguard Group, Inc.
4.84%
Other
69.08%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
25.50%
Investment Advisor
19.69%
Hedge Fund
17.14%
Individual Investor
8.96%
Venture Capital
7.24%
Pension Fund
2.27%
Research Firm
0.69%
Bank and Trust
0.11%
Family Office
0.07%
Other
18.33%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
212
35.78M
80.92%
-5.95M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
2023Q2
223
36.47M
86.49%
-881.53K
2023Q1
220
35.48M
86.11%
-356.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
AMH Equity, Ltd.
3.60M
8.14%
-170.35K
-4.52%
May 29, 2025
Weber Capital Management, LLC
3.20M
7.24%
+683.45K
+27.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.54M
5.75%
-164.85K
-6.09%
Mar 31, 2025
Harvey Partners, LLC
2.19M
4.95%
-495.50K
-18.47%
Mar 31, 2025
The Vanguard Group, Inc.
2.14M
4.84%
-19.11K
-0.89%
Mar 31, 2025
Green (James W)
2.03M
4.59%
+348.61K
+20.74%
Mar 20, 2025
Royce Investment Partners
1.78M
4.02%
-187.22K
-9.53%
Mar 31, 2025
272 Capital LLC
1.56M
3.52%
+1.56M
--
Sep 30, 2024
Granahan Investment Management, LLC
1.53M
3.46%
-89.28K
-5.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.44M
3.25%
-227.31K
-13.65%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Franklin US Small Cap Multifactor Index ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 Covered Call ETF
0%
WisdomTree US SmallCap Fund
0%
View more
Franklin US Small Cap Multifactor Index ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
DFA Dimensional US Core Equity Market ETF
Proportion0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
DFA Dimensional US Small Cap Value ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
WisdomTree US SmallCap Fund
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI